Aiduce and Sovape have recently made an official statement to the AFP contesting and denouncing “scaremongering based on false data about vaping products”. According to the two French pro-vaping associations, the AFP broacast false information that had previously been disproved by specialists. The subject of the letter of complaint was an article discussing cancer-related risks associated with e-cig usage. These risks were allegedly demonstrated by a study performed by the New York University Faculty of Medicine. Aiduce and Sovape are deploring the fact that the AFP did not check facts and reported on a study that had been run with “seriously flawed test specifications”. At the time, the news was covered here on BlogVape.
There is reason for concern, given the animal test subjects used in the study were said to spontaneously develop cancer. There is no information whatsoever on the type of e-cig device used in the tests. The study is quoted stating that emissions produced by the device were in gas form, when in fact e-cigs emit an aerosol. It also points to health risks considered “minor, at most” by the scientific community at large.
A source of worry for Aiduce and Sovape members
The study was communicated across a variety of media (either as extracts or with commentary). It has left a lot of people on edge. A number of association members contacted both Aiduce and Sovape to know if they should put down e-cigs and switch back to cigarettes until further notice. Others complained that their friends and family were constantly bringing up the topic. The consequences could be serious in terms of public health, given many smokers rely on e-cigs to help them quit cigarettes.
For these reasons, the two associates have requrested that the AFP retract the article, or at the very least publish a more balanced report on the study. Aiduce and Sovape are deploring the fact that, in the era of “fake news”, the AFP did not take the time to fact-check their publications more seriously.